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Abstract
Background: There is at present a lack of knowledge of time trends in health related quality of
life (HRQL) in common patients with coronary artery disease (CAD) treated in ordinary care. The
objective of this study is to assess and compare time trends of health related quality of life (HRQL)
and chest pain in patients with coronary artery disease.
Methods: 253 consecutive CAD patients in Stockholm County, Sweden – 197 males/56 females;
60 ± 8 years – were followed during two years. Perceived chest pain symptoms and three global
assessments of HRQL were assessed at baseline, after one and after two years. EuroQol-5
dimension (EQ-5D) with a predefined focus on function and symptoms; the broader tapping global
estimates of HRQL; EuroQol VAS (EQ-VAS) and Cardiac Health Profile (CHP) were used. Chest
pain was ranked according to Canadian Cardiovascular Society (CCS). Change in HRQL was
analysed by a repeated measurements ANOVA and chest pain symptoms were analysed by
Friedman non-parametric ANOVA.
Results: Perceived chest pain decreased during the two years (p < 0.00022); CCS 0: 41–51%; CCS
1: 19–15%; CCS 2: 31–27%; CCS 3: 5–4% and CCS 4: 4–2%. By contrast, HRQL did not change:
EQ-5D: 0.76 (CI 0.73–0.79) -0.78 (CI 0.75–0.81), EQ-VAS: 0.68 (CI 0.66–0.71)-0.68 (CI 0.65–0.71)
and CHP: 0.66 (CI 0.64–0.69) -0.66 (CI 0.64–0.69).
Conclusion: HRQL did not increase despite a reduction in the severity of chest pain during two
years. This implies that the major part of HRQL in these consecutive ordinary patients with CAD
is unresponsive to change in chest pain symptoms.
Background
Disease specific and all-cause mortality in patients with
coronary artery disease (CAD) have declined during the
last decades [1]. Patients with CAD have at present well
treated physical symptoms and cardiovascular drugs help
to reduce their risk of a new coronary event. However, the
patient's perception of disease is to a large extent unex-
plored. Health related quality of life (HRQL) is often
added as an outcome variable in randomised intervention
clinical trials with the aim to assess the patient's percep-
tion of the disease. HRQL is – in contrast to morbidity and
mortality – a multidimensional construct without a
golden standard or definition. HRQL is always assessed
and defined by the individual patient. Objective – e g pat-
ency – and subjective – e g HRQL – results are often in
conflict [2,3]. Some studies report improved perceived
Published: 6 March 2007
Health and Quality of Life Outcomes 2007, 5:13 doi:10.1186/1477-7525-5-13
Received: 6 December 2006
Accepted: 6 March 2007
This article is available from: http://www.hqlo.com/content/5/1/13
© 2007 Kiessling and Henriksson; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
Page 2 of 10
(page number not for citation purposes)
function and wellbeing after an intervention resulting in
similar levels of HRQL as in normative populations [4,5].
By contrast, in other studies patients examined e. g. four
years after an acute myocardial infarction still had a
decreased HRQL as compared to community norms [6]. A
problem with randomised controlled trials is that they
often include highly selected patient groups. This selec-
tion decreases the ability to extrapolate the effects, to the
unselected cohorts in routine care. Descriptive studies of
unselected populations with CAD receiving routine clini-
cal care are scarce. Studies examining time trends in such
populations are consequently even more scant. However,
in order to understand the patient perspective – illness –
of CAD it is mandatory to study HRQL in unselected
cohorts of patients. The aim of our study is to assess time
trends in chest pain symptoms and HRQL in routine care
patients with CAD.
Methods
Design and subjects
We identified a cohort of consecutive patients with CAD
and assessed chest pain symptoms and perceived quality
of life during two years. This was done in connection with
a randomised study showing that participatory learning of
secondary prevention for general practitioners decreased
cholesterol levels in their patients with coronary artery
disease [7].
The Department of Medicine at Södertälje Hospital,
located in the southernmost part of Stockholm County,
Sweden, provides planned and emergency health care for
acute and elective cardiac patients in a catchments area of
approximately 95 000 habitants. All in- and outpatients
with an age less or equal to 70 years who had visited the
department during the preceding year, due to symptoms
and signs of CAD (ICD-9 code 410–414) were identified
(1995). The age limit was chosen due to lack of secondary
preventive studies in older patients at time of recruitment.
429 patient records were investigated. 106 patients were
excluded, the majority because they did not fulfil the cri-
teria of CAD and a few because of other life threatening
disease or because they lived outside the catchments area.
68 of the remaining 323 patients fulfilling the criteria for
inclusion refused to participate.
Criteria for a confirmed diagnosis of CAD in the patient
record were:
I: A diagnosis of angina pectoris, either by objective crite-
ria based on coronary angiography, or a pathologic exer-
cise- or stress-test, or a clinical assessment based on typical
angina symptoms at exercise with or without ECG-evi-
dence of possible or definite ischemia.
II: A diagnosis of myocardial infarction based on either
WHO-criteria [8] or on unequivocal ECG-findings.
Hypertension was considered to be present if systolic
blood pressure was > 140 mm Hg, if diastolic blood pres-
sure was > 90 mm Hg or if antihypertensive medication
was used. Diabetes mellitus was defined as fasting plasma
glucose of ≥ 7.0 mmol/l, a self-reported history of diabetes
mellitus or treatment for diabetes.
The patients were examined and they answered question-
naires including symptoms of angina pectoris and HRQL
assessments at inclusion, after one respectively after two
years. Baseline characteristics are given in Table 1 and the
trial profile in figure 1. Further details of the patient
cohort, the inclusion procedure and two of the health
related quality of life instruments used in this study; the
Cardiac Health Profile questionnaire (CHP) and the Euro-
Qol-VAS instrument (EQ-VAS) are available in a previous
publication [9]. There were no significant differences in
assessed total CHP scores between patients with or with-
out a prior myocardial infarction or between those who
had or had not passed an intervention – Percutaneous
Coronary Intervention (PCI)/Coronary Artery Bypass Sur-
gery (CABG) – at baseline. Furthermore, a regression anal-
ysis showed no influence on HRQL of duration of CAD or
age [9].
The HRQL-questionnaires were self-completed. The
Swedish versions of the CHP- and EQ-instruments were
used. One research nurse performed all interviews and
physical examinations at the department. She also han-
dled all case report forms. All participating patients gave
written informed consent. The study complies with the
Declaration of Helsinki and was approved by the ethics
committee of Karolinska Institutet at Huddinge Univer-
sity Hospital.
Assessment of chest pain symptoms and health related 
quality of life
The patients ranked existence and degree of current
angina symptoms according to the Canadian Cardiovas-
cular Society classification (CCS) 0–4 [10] at baseline,
after one respectively two years (Table 2).
The definition of HRQL in this study is that 'quality of life'
in clinical medicine represents the functional effect of an
illness and its consequent therapy upon a patient, as per-
ceived by the patient [11].
The Cardiac health profile questionnaire (CHP) is a dis-
ease-specific HRQL questionnaire specially designed for
respondents with CAD. CHP assesses the HRQL in a
broad perspective. The questionnaire includes questions
about physical function/general health, emotional, socialHealth and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
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and cognitive function. The 16 items in the CHP question-
naire (English version) are shown in Table 3. For further
details of content, development, validity, reliability and
sensitivity in Swedish cohorts of patients with CAD see
previous publications [9,12,13]. The CHP yields an esti-
mate of HRQL between 0 and 100 were 0 is equal to full
health and 100 is equal to worst imaginable state. We
have in this study transformed the individual global CHP
mean scores to a 0–1 scale were 0 is equal to death and 1
is equal to full health. This was done in order to facilitate
comparison to the EuroQol results.
Multivariate explorative factor analytical methods were
used to identify the underlying structure as described in a
previous publication [9]. Four independent principal
components – sub-domains – of HRQL were identified.
These components are physical function/general health,
emotional, social and cognitive function.
The generic HRQL questionnaires EuroQol-5 Dimensions
(EQ-5D) self-classifier and EuroQol-VAS (EQ-VAS) were
used to test the robustness of the analysis of time trends of
HRQL as measured by the CHP questionnaire. In the EQ-
5D self classifier the respondents classified their own
health status in five aspects – mobility, self-care, usual
activities, pain/discomfort and anxiety/depression into
one of three levels – no problems, moderate problems
and severe problems [14,15]. Each obtained individual
health state was then given an index value (0–1) based on
a method described by Dolan [16]. Since there is no Swed-
ish tariff for EQ5D-index, the UK EQ5D-index tariff was
used to calculate the EQ5D-index values, were 0 is equal
to death and 1 is equal to full health [16]. Health states
worse than death were given a score of 0 since the scaling
of negative health states are controversial [17,18].
In the EQ-VAS method the respondent marks present
HRQL on a 20 cm vertical measurement scale with
labelled anchors 'dead' (0) and 'full health' (100). The
individual numbers marked on the scale were divided by
100 in order to obtain EQ-VAS scores between 0 and 1.
Both EQ5D methods are easy and rapid generic instru-
ments, well validated and found to be reliable in different
cultures and in different diseases including a new valida-
tion study in patients after myocardial infarction [19,20].
Statistics
The main outcome variable in the present study is change
in HRQL and chest pain (CCS) over time. HRQL was ana-
lysed by a repeated measurements ANOVA and chest pain
Table 1: Patient characteristics at baseline
Patients included (n) 253
Age (years) 60.1 ± 7.5
BMI (kg/m2) 28 ± 4.2
Waist/hip ratio 0.95 ± 0.07
Systolic blood pressure (mmHg) 139 ± 20
Diastolic blood pressure (mmHg) 84 ± 9
Duration of CAD (years) 6.0 ± 5.6
Total lipoprotein cholesterol 6.4 ± 1.1
Triglycerides 2.1 ± 1.1
High density lipoprotein cholesterol 1.2 ± 0.3
Low density lipoprotein cholesterol 4.2 ± 1.0
Men/Women 197 (78%)/56 (22%)
Family history of CAD 97 (38%)
Diabetes mellitus 37 (15%)
Hypertension 67 (26%)
Smoking
Non smoker 107 (42%)
Ex-smoker 85 (34%)
Current smoker 61 (24%)
History of myocardial infarction 167 (66%)
History of coronary artery bypass grafting 95 (38%)
History of PCI 29 (11%)
History of peripheral arterial disease 5 (2%)
History of cerebrovascular lesions 3 (1%)
Use of Acetyl salicylic acid 205 (81%)
Use of β-blockers 165 (65%)
Use of Lipid lowering drugs 49 (19%)
Other co-morbidity* 71 (28%)
Values are given as mean ± SD or n (%); BMI, Body Mass Index; CAD, Coronary Artery Disease; PCI, Percutaneus Coronary Intervention; *For 
example locomotive, gastro intestinal, pulmonary, depression, renal calculi and prostate disordersHealth and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
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symptoms were analysed by Friedman non-parametric
ANOVA. The underlying structure of HRQL as assessed by
CHP was explored by the factor analytic multivariate tech-
nique, principal component (PC) analysis. The 16 item
variables were reduced into principal components, i.e. to
avoid an influence of multicollinearities and to find
orthogonal (independent) factors explaining the variance
in the sample [21,22]. Another way to put this is to find
independent underlying factors explaining the variation
in answers. Varimax rotation was used. The Kaiser crite-
rion was used to demarcate the total number of factors
(principal components) to retain. Only factors with Eigen
values greater than 1 were retained; i.e. unless a factor
extracts at least as much as the equivalent of one original
variable, it was dropped. We have described the details in
a previous publication [9]. The factor coefficients of the
four extracted PC at baseline were used to calculate PC:s at
one respectively two years. The coefficients and the for-
mula used can be obtained from the corresponding
author. We used Spearman Rank order correlation analy-
sis to assess whether a co variation between chest pain
symptoms and HRQL existed. The descriptive data for the
HRQL measurements are given as mean and 95% confi-
dence interval. The patient's baseline characteristics are
given as mean ± SD or n (%). The power of the present
study is 80% to detect a change in EQ5D by 5%.
Results
The characteristics of the study population at baseline are
described in Table 1. 253 consecutive patients (197 males
and 56 females) with a mean age of 60.1 ± 7.5 years were
included. The response rates were 99% in all of the used
HRQL instruments at baseline. The response rate was 98%
on CCS. During the study five patients died and all of
those due to cardiovascular disease. In addition, two
patients had to be excluded due to another serious disease
Trial profile Figure 1
Trial profile. Inclusion, participation, dropouts and follow up.
Patients with
ICD-9 code 410-414
n=429
Patients with
a confirmed diagnos
of CAD n=323
Included patients
at baseline n=253
Patients followed
during two years
n=220
Patients answering all
questionnaires at all
three time points n=202
Excluded due to
miscoding or
life treatening disease
n=106
Refused to participate
n=68
Lost to follow up n=33
(CAD death n=5  other
serious disease n=2
other reasons n=26) 
Excluded from time
trend analysis due to
missing data at any
of the time points n=18Health and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
Page 5 of 10
(page number not for citation purposes)
and eight patients had moved out of the district and 18
patients refused participation (figure 1). Thus, we had
altogether 220 patients at the two years follow-up (88%).
202 patients answered CHP, EQ 5D, EQ-VAS and CCS at
all three assessments points (81% of all included patients
at baseline). There were no significant differences in base-
line characteristics between responders and non-respond-
ers.
Time trends
The prevalence and severity of chest pain symptoms –
according to CCS grade – decreased during the two study
years as shown in Table 2 (p < 0.00022). By contrast, no
significant change occurred in HRQL during the two years,
as assess by three different instruments (figure 2). Further-
more no change at all was noted in any of the four major
components of HRQL – cognitive, physical/general health
perception, social and emotional function – derived from
the CHP-instrument; (data not shown). During the study
67 (33%) of the patients contracted non cardiovascular
co-morbidity. Analysis with inclusion or exclusion of
these 67 patients did not change our results.
An analysis of co-variation between chest pain symptoms
and HRQL showed significant correlations between CCS
and all three global assessments of HRQL at all three time
points, Table 4 (p = 0.000000).
A similar analysis of the four independent sub-domains –
principal components – showed a correlation between
chest pain symptoms and the physical/general health
domain at all three time points (p = 0.000000). By con-
trast, there was no correlation between cognitive function
respectively social function domains and chest pain symp-
toms at any of the time points (Table 4). Figure 3 and 4
illustrates the different patterns of co-variation between
chest pain and the cognitive respectively physical/general
health domains of HRQL at baseline and at two years.
Table 3: Items in the Cardiac Health Profile questionnaire (CHP)
Item
1 How do you cope with tasks that require concentration and reflection?
2 Are you an active person, full of initiative or passive and listless?
3 Do you easily forget things in the immediate past or where, for example, you have placed things?
4 Do you easily understand and solve problems, make decisions adapt to new situations?
5 Do you feel depressed or have difficulty finding pleasure in things you used to find pleasant?
6 Do you easily become irritated, sad, worried, or anxious?
7 Do you often experience fear, uneasiness or anxiety?
8 Do you easily lose control over your feelings?
9 Are you satisfied with your sleep (quality of sleep, ability to fall asleep, etc.)?
10 Do you have a good relationship to those connected to you (family and friends)?
11 Are you satisfied with your daily life (at work, as a pensioner, as a housewife, as a student, etc.)?
12 Do you experience your leisure time as meaningful and enriching?
13 How is your sexual life?
14 Are you satisfied with your physical capacity to accomplish things you wish to do?
15 How do you experience your general health status?
16 Are you troubled by various kinds of pain other than your known anginal chest pain?
The answers are marked on a 100 mm VAS-scale with verbal anchors expressing extremes. High scores indicates a bad Health Related Quality of 
Life
Table 2: Prevalence and severity of chest pain symptoms ranked according to the Canadian Cardiovascular Society classification (CCS 
0–4)
n = 202 Baseline After 1 year After 2 years p < 0.00022*
CCS 0 No chest pain 82 (41%) 105 (52%) 104 (51%)
CCS 1 Ordinary physical activity does not cause angina. Strenuous, rapid, or prolonged 
exertion causes angina
39 (19%) 28 (14%) 30 (15%)
CCS 2 Slight limitation of ordinary activity (special circumstances) due to angina 62 (31%) 54 (27%) 55 (27%)
CCS 3 Marked limitation in ordinary physical activity due to angina 11 (5%) 10 (5%) 9 (4%)
CCS 4 Unable to perform any physical activity without discomfort – angina may be 
present at rest.
8 (4%) 5 (2%) 4 (2%)
Friedman non-parametric ANOVAHealth and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
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Discussion
The prevalence and severity of chest pain symptoms
decreased during two years of follow-up as assessed by
CCS grade in this unselected cohort of patients with CAD.
However, no change was found in global HRQL as
assessed by three different HRQL instruments despite the
symptom reduction. This indicates that an important part
of HRQL in such patients is unresponsive to change in the
existence or degree of chest pain. Several explanations to
this could be discussed. One possible confounder could
be a change in non-cardiac morbidity. However, a sepa-
rate analysis excluding patients contracting co-morbidity
during the study did not change the results. The reason for
the unresponsiveness could be the multidimensional con-
struct of HRQL. As shown in table 4 the CCS grade seems
to explain slightly more than one third of the variation in
EQ-5D and one sixth of the variation in CHP at each time
point. Looking at the main components of HRQL, CCS
explained slightly less than one fifth of the variation in
physical function, a minor fraction of the variation in
emotional function and none of the variation in cognitive
and social function at all time points. However, none of
these components changed during the time period.
We have in a previous paper found that perceived cogni-
tive function explains the major part of HRQL in this
cohort [9]. However, the result of the correlation analysis
showed no relation between perceived cognitive function
and chest pain symptoms. Studies exploring cognitive
function in CAD – either objectively measured or as per-
ceived by the patient – are scarce. We conclude that
important parts of HRQL in these patients do not depend
on chest pain symptoms. This finding is strengthened by
another study [23]. The effect of coronary artery bypass
graft surgery was assessed by the Medical Outcome Study
Short Form-36 (SF-36) questionnaire. HRQL improved in
Health related quality of life at different times of follow up assessed by Cardiac Health Profile (CHP), EuroQol-VAS (EQ-VAS)  and EuroQol-5 Dimension (EQ 5D-Index) instruments Figure 2
Health related quality of life at different times of follow up assessed by Cardiac Health Profile (CHP), EuroQol-VAS (EQ-VAS) 
and EuroQol-5 Dimension (EQ 5D-Index) instruments. Time trend during the two years was analysed by a repeated measure-
ment ANOVA.
 EQ 5D Index
 EQ-VAS
 CHP
Baseline After 1 year After 2 year
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
ns
ns
nsHealth and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
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6 of 8 subscales. However, general health and role emo-
tional scores did not improve in parallel to the decrease in
chest pain symptoms. This finding indicates that major
parts of HRQL – in patients with CAD – do not improve
in parallel to an improved physical function.
A limitation of our study is that that we just assessed per-
ceived function. However, the main aim was to evaluate
time trends in illness – both in terms of HRQL and chest
pain symptoms – and not primarily to address a compar-
ison between objective function and subjective percep-
tion. Furthermore it is known that the correlation is weak
between objectively measured cognitive function and per-
ceived cognitive function [24].
Strength of our study is that HRQL was assessed both by
three different global instruments and by the independent
sub-domains. The response rate was also high. This
should increase the robustness of our analysis and conclu-
sions. Another strength is that this large sample of patients
were followed over a good [2-year] period. Furthermore,
the cohort was unselected and included both patients
with and without present physical symptoms. This should
increase the ability to understand the comprehensiveness
of different assessment instruments and to analyse a puta-
tive co variation of change in HRQL and other estimates
over time.
The comprehensiveness differs between the three HRQL
instruments. EQ-VAS is an individually defined global
estimate. The 16 items of the CHP questionnaire taps – as
compared to other frequently used instruments – a broad
perspective of aspects on HRQL. It includes e g questions
concerning the ability to select relevant information, and
to understand, retain, express and apply knowledge in
specific contexts of life. In a previous analysis we showed
that questions representing cognitive function explained
43% of the HRQL variation [9]. EQ-5D includes five ques-
tions tapping five defined aspects of HRQL. It has been
demonstrated that adding a cognition attribute to the
standard EQ-5D system increases its comprehensiveness
[25].
There was a slight but insignificant improvement of
HRQL as assessed by EQ-5D (2.6%; p = 0.28). However,
the power analysis showed that we could exclude a more
clinically relevant improvement in HRQL by 5% or more
even in the symptom driven EQ-5D. EQ-5D also showed
a better global HRQL by 0.1 (p = 0.0000) than CHP and
EQ-VAS. An explanation might be the more narrow scope
Table 4: Correlation between chest pain symptoms and three different global measures of health related quality of life (HRQL) 
respectively to four independent domains of HRQL
n = 202 Spearman Rank t(N-2) p-value
EQ-5DIndex Baseline -0.58 -10.02 0.000000
After 1 year -0.60 -10.53 0.000000
After 2 years -0.64 -11.82 0.000000
EQVAS Baseline -0.48 -7.66 0.000000
After 1 year -0.52 -8.64 0.000000
After 2 years -0.48 -7.78 0.000000
CHP Baseline -0.39 -6.06 0.000000
After 1 year -0.45 -7.22 0.000000
After 2 years -0.35 -5.33 0.000000
PCcognitive Baseline 0.05 0.70 0.48
After 1 year 0.10 1.39 0.17
After 2 years 0.09 1.30 0.20
PCphysical/general Baseline 0.41 6.42 0.000000
After 1 year 0.47 7.45 0.000000
After 2 years 0.43 6.66 0.000000
PCsocial Baseline 0.11 1.63 0.10
After 1 year 0.23 3.32 0.001
After 2 years 0.08 1.14 0.25
PCemotional Baseline 0.18 2.65 0.009
After 1 year 0.21 3.09 0.002
After 2 years 0.15 2.08 0.04
Spearman Rank Order Correlation between existence and severity of current chest pain symptoms assessed by Canadian Cardiovascular Society 
classification CCS (0–4) and different measures of health related quality of life
EQ-5DIndex denotes EuroQol 5 Dimension questionnaire transformed to an Index score (0–1)
EQVAS denotes EuroQol-VAS instrument (0–1)
CHP denotes the Cardiac Health Profile questionnaire (global mean score)
PC denotes the four independent domains of HRQL calculated from the CHP questionnaireHealth and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
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of EQ-5D tapping mainly physical and emotional aspects
of HRQL.
It is known that physicians tend to underestimate or fail
to recognise functional disabilities that are reported by
their patients, especially disabilities related to social activ-
ities [26]. The physician has a disease perspective and
translates the absence or decrease of chest pain symptoms
to less stenotic coronary arteries with improved capacity
to distribute oxygen to fulfil the demand of the working
myocardial tissue. This should improve the patients' phys-
ical function. However, the patients' perception of health
might have a great inertia to respond to decreased chest
pain symptoms. All patients in the present study knew
that their coronary arteries were affected by atherosclero-
sis. To many patients this knowledge might mean that
they constantly are afflicted by a potentially lethal condi-
tion.
A limitation and strength of the present study is of course
the unselected sample in concert with the fact that the
patients are included from a single geographic area. The
study addresses an important issue about responsiveness
of HRQL instruments. Our findings of a low sensitivity of
the HRQL instruments to change in symptom burden is
interesting and challenging both from a clinical and soci-
etal perspective. The results should stimulate future
research on the complex relations between objectively
measured disease and subjectively perceived illness for
patients with CAD.
Conclusion
The major part of assessed health related quality of life is
unresponsive to a decrease in severity of chest pain symp-
toms in a consecutive cohort of ordinary patients with cor-
onary artery disease. This indicates that a reduction of
chest pain symptoms is not sufficient; to improve health
Covariation of chest pain grade and and the physical/general health and cognitive domains of health related quality of life at  baseline Figure 3
Covariation of chest pain grade and and the physical/general health and cognitive domains of health related quality of life at 
baseline. Chest pain is assessed by Canadian Cardiovascular Society classification (CCS; 0–4). Values are given as mean ± SE. 
Spearman Rank order correlation analysis was used.
Baseline
01234
CCS
-0,8
-0,6
-0,4
-0,2
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
1,6
1,8
Perceived cognitive function
R=0.05 (ns)
Physical/General function
R=0.41 (p=0.000000)Health and Quality of Life Outcomes 2007, 5:13 http://www.hqlo.com/content/5/1/13
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related quality of life in patients with coronary artery dis-
ease. The dominating dimension of health related quality
of life – cognitive function – does not differ between
patients with or without chest pain symptoms. The low
responsiveness of assessed health related quality of life
outcome to a change in symptom burden is interesting
and challenging both from a clinical and a public health
perspective.
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